Salud Mental

Evaluation of hormonal and metabolic factors related to depression in reproductive age women

##plugins.themes.bootstrap3.article.main##

Martín Armando Burrola-Suárez
Rodrigo Guiza-Zayas
J. Miguel Enciso-Araujo
Dannia Islas-Preciado
Erika Estrada Camarena

Abstract

Introduction. Major depressive disorder (MDD) is a prevalent disease affecting women more than men worldwide. Various factors are involved in the genesis of depression, including hormones such as testosterone and certain metabolic factors

Objective. To evaluate hormone levels and metabolic variables in women with major depression and healthy controls.

Method. A cross-sectional, comparative analytical study was conducted in 40 participants, 23 patients with an MDD diagnosis and 17 controls, all of women in reproductive age between the ages of 18 and 45. Sociodemographic variables, hormonal profile, and metabolic variables were assessed and the 17-item Hamilton Depression Scale was used to evaluate depressive symptoms.

Results. No statistically significant differences were observed between the groups in the hormonal and metabolic variables explored. Nevertheless, it was observed that the lower the testosterone levels and the higher the serum glucose levels, the more intense depressive symptoms were.

Discussion and conclusion. Testosterone is associated with a lower depressive symptoms score on the Hamilton Depression scale, suggesting a potential antidepressant effect, whereas high glucose levels are associated with a higher score on this scale. We believe that the measurement of hormonal and metabolic variables in women can contribute to a better understanding of the pathophysiology of depression.
Keywords:
Major depressive disorder (MDD), testosterone, glucose, hormones

Downloads

Download data is not yet available.

References

Arthur, R., Rohrmann, S., Moller, H., Selvin, E., Dobs, A. S., Kanarek, N., ... Van Hemelrijck, M. (2017). Pre-diabetes and serum sex steroid hormones among US men. Andrology, 5(1), 49-57. doi: 10.1111/andr.12287

Asadikaram, G., Khaleghi, E., Sayadi, A., Foulady, S., Ghasemi, M. S., Abolhassani, M., ... Nematollahi, M. H. (2019). Assessment of hormonal alterations in major depressive disorder: A clinical study. Psych Journal, 8(4), 423-430. doi: 10.1002/pchj.290

Atlantis, E., Fahey, P., Martin, S., O’Loughlin, P., Taylor, A. W., Adams, R. J., ... Wittert, G. (2016). Predictive value of serum testosterone for type 2 diabetes risk assessment in men. BMC Endocrine Disorders, 16(1), 26. doi: 10.1186/s12902-016-0109-7

Basaria, S., Muller, D. C., Carducci, M. A., Egan, J., & Dobs, A. S. (2006). Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer, 106(3), 581-588. doi: 10.1002/cncr.21642

Bobes, J. (1998). A Spanish validation study of the mini international neuropsychiatric interview. European Psychiatry, 13(Suppl 4), 198s-199s. doi: 10.1016/S0924-9338(99)80240-5

Bromberger, J. T., & Epperson, C. N. (2018). Depression during and after the perimenopause: Impact of hormones, genetics, and environmental determinants of disease. Obstetrics and Gynecology Clinics, 45(4), 663-678. doi: 10.1016/j.ogc.2018.07.007

Carrier, N., Saland, S. K., Duclot, F., He, H., Mercer, R., & Kabbaj, M. (2015). The anxiolytic and antidepressant-like effects of testosterone and estrogen in gonadectomized male rats. Biological Psychiatry, 78(4), 259-269. doi: 10.1016/j.biopsych.2014.12.024

Celec, P., Ostatníková, D., & Hodosy, J. (2015). On the effects of testosterone on brain behavioral functions. Frontiers in Neuroscience, 9, 12-12. doi: 10.3389/fnins.2015.00012

Fiacco, S., Walther, A., & Ehlert, U. (2019). Steroid secretion in healthy aging. Psychoneuroendocrinology, 105, 64-78. doi: 10.1016/j.psyneuen.2018.09.035

Flores-Ramos, M., Alcauter, S., Lopez-Titla, M., Bernal-Santamaria, N., Calva-Coraza, E., & Edden, R. A. E. (2019). Testosterone is related to GABA+ levels in the posterior-cingulate in unmedicated depressed women during reproductive life. Journal Affective Disorders, 242(1), 143-149. doi: 10.1016/j.jad.2018.08.033

Ford, A. H., Yeap, B. B., Flicker, L., Hankey, G. J., Chubb, S. A., Handelsman, D. J., ... Almeida, O. P. (2016). Prospective longitudinal study of testosterone and incident depression in older men: The health in men study. Psychoneuroendocrinology, 64, 57-65. doi: 10.1016/j.psyneuen.2015.11.012

Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W., van Pelt, J., Spinhoven, P., & Roelofs, K. (2012). Salivary testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. Journal Psychosomatic Research, 72(3), 205-213. doi: 10.1016/j.jpsychores.2011.11.014

Hamilton, M. (1960). A rating scale for depression. Journal Neurology, Neurosurgery, and Psychiatry, 23(1), 56-62. doi: 10.1136/jnnp.23.1.56

Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., ... Group, S. C. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. The Jornual of Clinical Endocrinology & Metabolism, 97(4), 1159-1168. doi: 10.1210/jc.2011-3362

Heinze, M., Sheehan, D., & Cortés, J. (2000). Mini International Neuropsychiatric Interview (MINI): Spanish version (South and Central America) 5.0.0 DSM-IV. México, DF: Instituto Nacional de Psiquiatría.

Institute for Health Metrics and Evaluation. (2018). Findings from the Global Burden of Disease Study 2017. Seattle, WA: IHME.

Kheirbek, M. A., Klemenhagen, K. C., Sahay, A., & Hen, R. (2012). Neurogenesis and generalization: a new approach to stratify and treat anxiety disorders. Nature Neuroscience, 15(12), 1613-1620. doi: 10.1038/nn.3262

Kische, H., Pieper, L., Venz, J., Klotsche, J., März, W., Koch-Gromus, U., ... Haring, R. (2018). Longitudinal change instead of baseline testosterone predicts depressive symptoms. Psychoneuroendocrinology, 89, 7-12. doi: 10.1016/j.psyneuen.2017.12.013

Ko, J. Y., Farr, S. L., Dietz, P. M., & Robbins, C. L. (2012). Depression and treatment among U.S. pregnant and nonpregnant women of reproductive age, 2005-2009. Journal of Women’s Health, 21(8), 830-836. doi: 10.1089/jwh.2011.3466

Kuehner, C. (2017). Why is depression more common among women than among men?. Lancet Psychiatry, 4(2), 146-158. doi: 10.1016/S2215-0366(16)30263-2

Leal, S. L., Tighe, S. K., & Yassa, M. A. (2014). Asymmetric effects of emotion on mnemonic interference. Neurobiology of Learning and Memory, 111, 41-48. doi: 10.1016/j.nlm.2014.02.013

Matsuzaka, H., Maeshima, H., Kida, S., Kurita, H., Shimano, T., Nakano, Y., ... Arai, H. (2013). Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls. The International Journal of Psychiatry in Medicine, 46(2), 203-221. doi: 10.2190/PM.46.2.g

McHenry, J., Carrier, N., Hull, E., & Kabbaj, M. (2014). Sex differences in anxiety and depression: role of testosterone. Frontiers in Neuroendocrinology, 35(1), 42-57. doi: 10.1016/j.yfrne.2013.09.001

Milman, L. W., Sammel, M. D., Barnhart, K. T., Freeman, E. W., & Dokras, A. (2015). Higher serum total testosterone levels correlate with increased risk of depressive symptoms in Caucasian women through the entire menopausal transition. Psychoneuroendocrinology, 62, 107-113. doi: 10.1016/j.psyneuen.2015.07.612

Morford, J., & Mauvais-Jarvis, F. (2016). Sex differences in the effects of androgens acting in the central nervous system on metabolism. Dialogues Clinical Neuroscience, 18(4), 415-424.

Ramos-Brieva, J. A., & Cordero Villafáfila, A (1986). Validacion de la version castellana de la escala de Hamilton para la depresion. Actas Luso Esp Neurol Psiquiatr, 14(4), 324-334. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/3776732

de la Roca-Chiapas, J. M., Hernandez-Gonzalez, M., Candelario, M., Villafaña M. de L., Hernandez, E., Solorio, S., ... Jasso, J. (2013). Association between depression and higher glucose levels in middle-aged Mexican patients with diabetes. Revista Investigación Clínica, 65(3), 209-213.

Salari-Moghaddam, A., Saneei, P., Larijani, B., & Esmaillzadeh, A. (2019). Glycemic index, glycemic load, and depression: a systematic review and meta-analysis. European Journal of Clinical Nutrition, 73(3), 356-365. doi: 10.1038/s41430-018-0258-z

Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., ... Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22-33;quiz 34-57.

Studd, J., & Panay, N. (2004). Hormones and depression in women. Climacteric, 7(4), 338-346. doi: 10.1080/13697130400012262

Walther, A., Wasielewska, J. M., & Leiter, O. (2019). The antidepressant effect of testosterone: An effect of neuroplasticity? Neurology, Psychiatry and Brain Research, 32, 104-110. doi: 10.1016/j.npbr.2019.05.004

Weber, B., Lewicka, S., Deuschle, M., Colla, M., & Heuser, I. (2000). Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology, 25(8), 765-771. doi: 10.1016/s0306-4530(00)00023-8

Willner, P., Scheel-Krüger, J., & Belzung, C. (2013). The neurobiology of depression and antidepressant action. Neuroscience & Biobehavioral Reviews, 37(10 Pt 1), 2331-2371. doi: 10.1016/j.neubiorev.2012.12.007

Zarrouf, F. A., Artz, S., Griffith, J., Sirbu, C., & Kommor, M. (2009). Testosterone and depression: Systematic review and meta-analysis. Journal of Psychiatric Practice, 15(4), 289-305. doi: 10.1097/01.pra.0000358315.88931.fc